Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126865771 | 12686577 | 1 | I | 20160704 | 20160816 | 20160825 | 20160825 | EXP | FR-PFIZER INC-2016389721 | PFIZER | 60.00 | YR | F | Y | 0.00000 | 20160825 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126865771 | 12686577 | 1 | PS | Dalacine | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 9 DF, 1X/DAY | 36 | DF | Y | 50162 | 9 | DF | CAPSULE, HARD | QD | |||
| 126865771 | 12686577 | 2 | SS | CLAMOXYL /00249601/ | AMOXICILLIN | 1 | Oral | 16 G, 1X/DAY | 64 | G | Y | 0 | 16 | G | DISPERSIBLE TABLET | QD | |||
| 126865771 | 12686577 | 3 | SS | ARIXTRA | FONDAPARINUX SODIUM | 1 | Subcutaneous | 1 DF, 1X/DAY | 8 | DF | Y | 0 | 1 | DF | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QD | |||
| 126865771 | 12686577 | 4 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 40 MG, 1X/DAY | 600 | MG | Y | 0 | 40 | MG | PROLONGED-RELEASE TABLET | QD | |||
| 126865771 | 12686577 | 5 | SS | OXYNORMORO | OXYCODONE | 1 | Oral | UNK, AS NEEDED | Y | 0 | DISPERSIBLE TABLET | ||||||||
| 126865771 | 12686577 | 6 | SS | DEDROGYL | CALCIFEDIOL | 1 | Oral | 5 GTT, 1X/DAY | 25 | Gtt | 0 | 5 | GTT | ORAL DROPS, SOLUTION | QD | ||||
| 126865771 | 12686577 | 7 | C | ZYVOXID | LINEZOLID | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 8 | C | TIENAM | CILASTATIN SODIUMIMIPENEM | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 9 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 10 | C | ARANESP | DARBEPOETIN ALFA | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 11 | C | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 12 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 13 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 14 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 15 | C | DOLIPRANE | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 16 | C | NOVORAPID | INSULIN ASPART | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 17 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 18 | C | FRAGMINE | DALTEPARIN SODIUM | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 19 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 20 | C | IPRATROPIUM BROMIDE MONOHYDRATE | IPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 21 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 22 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 23 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | 0 | CAPSULE | |||||||||||
| 126865771 | 12686577 | 24 | C | LEVEMIR | INSULIN DETEMIR | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 25 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 26 | C | MAGNE B6 /00869101/ | 2 | 0 | |||||||||||||
| 126865771 | 12686577 | 27 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 28 | C | SETOFILM | ONDANSETRON | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 29 | C | SPECIAFOLDINE | FOLIC ACID | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 30 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 31 | C | TARDYFERON | FERROUS SULFATE | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 32 | C | TEMESTA /00273201/ | LORAZEPAM | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 33 | C | TOPALGIC | TRAMADOL | 1 | 0 | ||||||||||||
| 126865771 | 12686577 | 34 | C | UVEDOSE | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126865771 | 12686577 | 1 | Osteitis |
| 126865771 | 12686577 | 2 | Osteitis |
| 126865771 | 12686577 | 3 | Pulmonary embolism |
| 126865771 | 12686577 | 4 | Gait disturbance |
| 126865771 | 12686577 | 5 | Gait disturbance |
| 126865771 | 12686577 | 6 | Vitamin D deficiency |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126865771 | 12686577 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126865771 | 12686577 | Eosinophilia | |
| 126865771 | 12686577 | Generalised erythema | |
| 126865771 | 12686577 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126865771 | 12686577 | 1 | 20160701 | 20160704 | 0 | |
| 126865771 | 12686577 | 2 | 20160701 | 20160705 | 0 | |
| 126865771 | 12686577 | 3 | 20160627 | 20160704 | 0 | |
| 126865771 | 12686577 | 4 | 20160620 | 20160704 | 0 | |
| 126865771 | 12686577 | 5 | 20160620 | 20160704 | 0 | |
| 126865771 | 12686577 | 6 | 20160629 | 20160703 | 0 |